Thesis
Venture capital for life science technologies addressing high-burden global public health challenges in underserved markets.
Stages
Series ASeries BSeries CGrowth
Sectors
BiotechHealthcare/MedtechLife SciencesClimate/Sustainability
Fund
- Current fund
- Adjuvant Global Health Technology Fund · 2020 · $$300M
- AUM
- $$300M
- Check size
- $10M – $25M
